Biocon launches liraglutide for diabetes and obesity in the Netherlands EP News Bureau Dec 15, 2025 The products are marketed as Diavorin and Vobexoryn through Pharmamedic B.V.
GLP-1R agonists can redefine chronic disease treatment beyond diabetes and obesity EP News Bureau May 5, 2025 GlobalData’s latest report showcases an analysis of the GLP-1R agonists pipeline in multiple indications, highlighting the areas…
